Rare disease model development is revolutionizing biomedical research by providing innovative approaches to studying and addressing rare diseases. Through the use of advanced technologies and bioengineered disease models, our company is making significant strides in understanding disease mechanisms and developing personalized therapies. We provide complete rare disease model development services to meet your various needs in the research and development of rare disease therapies. Learn more: Models of Rare Diseases
![Default_avatar](https://d1m4mcbi1h9acc.cloudfront.net/assets/default_avatar-a14ed5cf56b2a462ac226b5158d09c86.png)
cathyy smith, Rare disease research
Embryo-fetal development (EFD) toxicity evaluation is the second segment of developmental and reproductive toxicology evaluation. With many years of experience in rare disease therapy research and a proven track record of quality, innovation, and customer support, our company provides comprehensive services for embryo-fetal development toxicity evaluation to leading and emerging biopharmaceutical companies and scientific research institutions. Learn more:Embryo-fetal developmental toxicity
Diagnostic development aims to provide fast and reliable strategies for disease identification and detection. With the continuous innovation in technology of medical sciences, diagnostic development has greatly improved the early diagnosis and individualized treatment of rare diseases. Our company provides comprehensive services and mature solutions to help you speed up the diagnostic development in rare diseases. Learn more:Diagnostics Development
Alzheimer's disease is the leading cause of dementia, accounting for about two-thirds of all dementia cases. This common neurodegenerative disease usually results in severe memory impairment. The lack of effective cures makes it important to increase the development and characterization of relevant animal models to facilitate disease mechanisms and drug development research.
Our company' scientific team has extensive expertise in providing clients with scientifically sound and reliable animal models of Alzheimer's disease to facilitate their research in related diseases, based on scientific methodological techniques and evaluation tools. Learn more:Alzheimer's Disease Models
Dose Range Finding Studies Single-dose Toxicity Evaluation Repeated-dose Toxicity Evaluation Genetic Toxicology Evaluation
Chromosomal Aberration Assay Microwell Micronucleus Assay Bacterial Mutation Assay Developmental and Reproductive Toxicity Evaluation
Fertility and Early Embryo Development Toxicity Embryo-fetal Development Toxicity Perinatal Toxicity